NanoViricides
NNVC
#10114
Rank
โ‚ฌ19.9 M
Marketcap
1,11ย โ‚ฌ
Share price
-1.52%
Change (1 day)
-21.29%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -0,62ย โ‚ฌ

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -0,57ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,60ย โ‚ฌ an increase over its 2023 EPS that were of -0,63ย โ‚ฌ.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,62ย โ‚ฌ3.9%
2024-0,60ย โ‚ฌ-5.41%
2023-0,63ย โ‚ฌ5.71%
2022-0,60ย โ‚ฌ-13.58%
2021-0,69ย โ‚ฌ-66.11%
2020-2,03ย โ‚ฌ1.7%
2019-2,00ย โ‚ฌ-10.98%
2018-2,25ย โ‚ฌ-22.35%
2017-2,89ย โ‚ฌ-10.53%
2016-3,23ย โ‚ฌ375%
2015-0,68ย โ‚ฌ-85.19%
2014-4,59ย โ‚ฌ42.11%
2013-3,23ย โ‚ฌ26.67%
2012-2,55ย โ‚ฌ-6.25%
2011-2,72ย โ‚ฌ14.28%
2010-2,38ย โ‚ฌ100%
2009-1,19ย โ‚ฌ-0%
2008-1,19ย โ‚ฌ-33.33%
2007-1,79ย โ‚ฌ-0%
2006-1,79ย โ‚ฌ4445.07%
2005-0,03931ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-0,04254ย โ‚ฌ-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
1,80ย โ‚ฌ-416.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5,55ย โ‚ฌ-1,073.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,53ย โ‚ฌ-543.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,46ย โ‚ฌ-1,233.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,06ย โ‚ฌ-636.71%๐Ÿ‡ฌ๐Ÿ‡ง UK